Intravitreal ranibizumab for neovascular age-related macular degeneration patients with good baseline visual acuity and the predictive factors for visual outcomes


Ozkaya A., Alkin Z., Osmanbasoglu O. A. , Ozkaya H. M. , Demirok A.

JOURNAL FRANCAIS D OPHTALMOLOGIE, vol.37, no.4, pp.280-287, 2014 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 37 Issue: 4
  • Publication Date: 2014
  • Doi Number: 10.1016/j.jfo.2013.08.006
  • Journal Name: JOURNAL FRANCAIS D OPHTALMOLOGIE
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.280-287

Abstract

Purpose. - To evaluate the efficiency fo intravitreal ranibizumb for the treatment of neovascular age-related macular degeneration (nAMD) patients with a visual acuity (VA) of >= 20/40 and to investigate the predictive factors for visual outcomes.